861 reports of this reaction
1.5% of all MEDROXYPROGESTERONE ACETATE reports
#10 most reported adverse reaction
FATIGUE is the #10 most commonly reported adverse reaction for MEDROXYPROGESTERONE ACETATE, manufactured by Pharmacia & Upjohn Company LLC. There are 861 FDA adverse event reports linking MEDROXYPROGESTERONE ACETATE to FATIGUE. This represents approximately 1.5% of all 57,188 adverse event reports for this drug.
Patients taking MEDROXYPROGESTERONE ACETATE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for MEDROXYPROGESTERONE ACETATE, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for MEDROXYPROGESTERONE ACETATE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 861 FDA reports for MEDROXYPROGESTERONE ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 1.5% of all adverse event reports for MEDROXYPROGESTERONE ACETATE, making it a notable side effect.
If you experience fatigue while taking MEDROXYPROGESTERONE ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.